glp-1 class drugs New Guidelines for Type 2 Diabetes in 2025 The Rise of GLP-1 Medications

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence

The first six amino acids at the N-terminus of GLP-1, are further truncated by post-translational processing in the intestinal cells resulting in forming ~31 amino acid peptides - GLP-1(7-37) or GLP-1-(7-36) as shown in Figure 4 below

34.5 per 100,000 person-years, HR 1.75, 95% CI 1.222.49) in a population-based study [107]

Heart disease: You might need extra heart tests

After an average of 25 months, the primary composite outcome of CV death, myocardial infarction, stroke, or hospitalization for unstable angina occurred in 13.4% of individuals in the lixisenatide group compared to 13.2% in the placebo group (hazard ratio [HR] 1.02